These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37116389)

  • 21. Data-Driven Quantitative Susceptibility Mapping Using Loss Adaptive Dipole Inversion (LADI).
    Kamesh Iyer S; Moon BF; Josselyn N; Ruparel K; Roalf D; Song JW; Guiry S; Ware JB; Kurtz RM; Chawla S; Nabavizadeh SA; Witschey WR
    J Magn Reson Imaging; 2020 Sep; 52(3):823-835. PubMed ID: 32128914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Appropriate echo time selection for quantitative susceptibility mapping.
    Kanazawa Y; Matsumoto Y; Harada M; Hayashi H; Matsuda T; Otsuka H
    Radiol Phys Technol; 2019 Jun; 12(2):185-193. PubMed ID: 30980255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. QSM reconstruction challenge 2.0: A realistic in silico head phantom for MRI data simulation and evaluation of susceptibility mapping procedures.
    Marques JP; Meineke J; Milovic C; Bilgic B; Chan KS; Hedouin R; van der Zwaag W; Langkammer C; Schweser F
    Magn Reson Med; 2021 Jul; 86(1):526-542. PubMed ID: 33638241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid automated liver quantitative susceptibility mapping.
    Jafari R; Sheth S; Spincemaille P; Nguyen TD; Prince MR; Wen Y; Guo Y; Deh K; Liu Z; Margolis D; Brittenham GM; Kierans AS; Wang Y
    J Magn Reson Imaging; 2019 Sep; 50(3):725-732. PubMed ID: 30637892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deep grey matter quantitative susceptibility mapping from small spatial coverages using deep learning.
    Zhu X; Gao Y; Liu F; Crozier S; Sun H
    Z Med Phys; 2022 May; 32(2):188-198. PubMed ID: 34312047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative susceptibility mapping using principles of echo shifting with a train of observations sequence on 1.5T MRI.
    Kan H; Arai N; Kasai H; Kunitomo H; Hirose Y; Shibamoto Y
    Magn Reson Imaging; 2017 Oct; 42():37-42. PubMed ID: 28526432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of liver quantitative susceptibility mapping across imaging parameters at 1.5 T and 3.0 T using SQUID susceptometry as reference.
    Zhao R; Velikina J; Reeder SB; Vasanawala S; Jeng M; Hernando D
    Magn Reson Med; 2023 Apr; 89(4):1418-1428. PubMed ID: 36408802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of quantitative susceptibility mapping methods on evaluating radiation-induced cerebral microbleeds and basal ganglia at 3T and 7T.
    Chen Y; Genc O; Poynton CB; Banerjee S; Hess CP; Lupo JM
    NMR Biomed; 2022 May; 35(5):e4666. PubMed ID: 35075701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Quantitative magnetic resonance imaging of brain iron deposition: comparison between quantitative susceptibility mapping and transverse relaxation rate (R2*) mapping].
    Guan JJ; Feng YQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Mar; 38(3):305-311. PubMed ID: 29643036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How to accurately quantify brain magnetic susceptibility in the context of Parkinson's disease: Validation on phantoms and healthy volunteers at 1.5 and 3 T.
    Hervouin A; Bézy-Wendling J; Noury F
    NMR Biomed; 2024 Nov; 37(11):e5182. PubMed ID: 38993048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of low resolution and coverage on the accuracy of susceptibility mapping.
    Karsa A; Punwani S; Shmueli K
    Magn Reson Med; 2019 Mar; 81(3):1833-1848. PubMed ID: 30338864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of quantitative susceptibility mapping methods for iron-sensitive susceptibility imaging at 7T: An evaluation in healthy subjects and patients with Huntington's disease.
    Yao J; Morrison MA; Jakary A; Avadiappan S; Chen Y; Luitjens J; Glueck J; Driscoll T; Geschwind MD; Nelson AB; Villanueva-Meyer JE; Hess CP; Lupo JM
    Neuroimage; 2023 Jan; 265():119788. PubMed ID: 36476567
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decompose quantitative susceptibility mapping (QSM) to sub-voxel diamagnetic and paramagnetic components based on gradient-echo MRI data.
    Chen J; Gong NJ; Chaim KT; Otaduy MCG; Liu C
    Neuroimage; 2021 Nov; 242():118477. PubMed ID: 34403742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recommended implementation of quantitative susceptibility mapping for clinical research in the brain: A consensus of the ISMRM electro-magnetic tissue properties study group.
    ; Bilgic B; Costagli M; Chan KS; Duyn J; Langkammer C; Lee J; Li X; Liu C; Marques JP; Milovic C; Robinson SD; Schweser F; Shmueli K; Spincemaille P; Straub S; van Zijl P; Wang Y;
    Magn Reson Med; 2024 May; 91(5):1834-1862. PubMed ID: 38247051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of iron content in human cerebral cavernous malformation using quantitative susceptibility mapping.
    Tan H; Liu T; Wu Y; Thacker J; Shenkar R; Mikati AG; Shi C; Dykstra C; Wang Y; Prasad PV; Edelman RR; Awad IA
    Invest Radiol; 2014 Jul; 49(7):498-504. PubMed ID: 24619210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative Susceptibility Mapping of Amyloid-β Aggregates in Alzheimer's Disease with 7T MR.
    Tiepolt S; Schäfer A; Rullmann M; Roggenhofer E; ; Gertz HJ; Schroeter ML; Patt M; Bazin PL; Jochimsen TH; Turner R; Sabri O; Barthel H
    J Alzheimers Dis; 2018; 64(2):393-404. PubMed ID: 29865069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phantom validation of quantitative susceptibility and dynamic contrast-enhanced permeability MR sequences across instruments and sites.
    Hobson N; Polster SP; Cao Y; Flemming K; Shu Y; Huston J; Gerrard CY; Selwyn R; Mabray M; Zafar A; Girard R; Carrión-Penagos J; Chen YF; Parrish T; Zhou XJ; Koenig JI; Shenkar R; Stadnik A; Koskimäki J; Dimov A; Turley D; Carroll T; Awad IA
    J Magn Reson Imaging; 2020 Apr; 51(4):1192-1199. PubMed ID: 31515878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fast quantitative susceptibility mapping using 3D EPI and total generalized variation.
    Langkammer C; Bredies K; Poser BA; Barth M; Reishofer G; Fan AP; Bilgic B; Fazekas F; Mainero C; Ropele S
    Neuroimage; 2015 May; 111():622-30. PubMed ID: 25731991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative susceptibility mapping (QSM) minimizes interference from cellular pathology in R2* estimation of liver iron concentration.
    Li J; Lin H; Liu T; Zhang Z; Prince MR; Gillen K; Yan X; Song Q; Hua T; Zhao X; Zhang M; Zhao Y; Li G; Tang G; Yang G; Brittenham GM; Wang Y
    J Magn Reson Imaging; 2018 Oct; 48(4):1069-1079. PubMed ID: 29566449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantifying brain iron deposition in patients with Parkinson's disease using quantitative susceptibility mapping, R2 and R2.
    Barbosa JH; Santos AC; Tumas V; Liu M; Zheng W; Haacke EM; Salmon CE
    Magn Reson Imaging; 2015 Jun; 33(5):559-65. PubMed ID: 25721997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.